Previous close | 151.02 |
Open | 153.88 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 153.48 - 153.88 |
52-week range | 118.16 - 153.88 |
Volume | |
Avg. volume | 4,406 |
Market cap | 238.649B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 37.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.86 (1.89%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Our writer explains how he'd maximise his investment allowance in a Stocks and Shares ISA to target £10k in tax-free passive income every year. The post £20,000 in cash? Here’s how I’d aim for £10,000 in annual passive income! appeared first on The Motley Fool UK.
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expectations were $1.22. AstraZeneca PLC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning to those joining […]
European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in numerous cases. Lawyers representing the plaintiffs argue that the vaccine resulted in side effects for a small number of families, including brain injuries and fatalities. AstraZeneca, while contesting the claims, has acknowledged in court documents that its vaccine can, in rare instances, cause Thro